Table 1 Patient’s laboratory test results in admission and at discharge
From: Stroke associated with Mycoplasma hominis infection: a case report
Test normal values | In admission | Discharge | Test | In admission | Discharge |
|---|---|---|---|---|---|
WBC 3.8–10.5 K/μL | 11.14 | 7.35 | Glucose 74–106 mg/dl | 222 | 98 |
RBC 4.20–6.30 M/μL | 4.93 | 5.04 | Urea 16.6–48.5 mg/dl | 15 | 26 |
HGB 14.0–18.0 g/dL | 12.8 | 13.2 | Creatinine 0.7–1.2 mg/dl | 0.76 | 0.84 |
HCT 40.0–52.0 % | 40.0 | 41.8 | K+ 3.5–5.1 mmol/l | 4.5 | 4.6 |
MCV 80.0–99.0 fL | 81.1 | 82.9 | Na+ 136–145 mmol/l | 137 | 137 |
MCH 27.0–32.0 pg | 26.0 | 26.2 | Ca 2+ 8.6–10.2 mg/dl | 9 | 10.0 |
MCHC 32.0–35.0 g/dl | 32.0 | 31.6 | P 3.0–4.5 mg/dL | 3.6 | 4.3 |
PLT 150–450 K/μL | 399 | 311 | Mg 1.6–2.6 mg/dl | 1.90 | 1.97 |
ESR 0–20 mm | 62 | 47 | Bilirubin –total <= 1.4 mg/dl | 0.30 | 0.50 |
PT% | 74 | 58 | Bilirubin-direct 0.00–0.30 mg/dl | 0.14 | 0.21 |
INR 0.85–1.15 INR | 1.18 | 1.35 | SGOT < 40 U/l | 8 | 15 |
APTT 25–35 sec | 21.9 | SGPT 0–41 U/l | 15 | 27 | |
Fibrinogen 200–450 mg/dl | 606 | 488 | γ-GT 8–61 U/l | 41 | 25 |
D-dimers < 0.4 mcg/ml | 0.51 | 0.11 | ALP 30–120 units /l | 103 | 98 |
PLT 150–450 K/μL | 399 | 311 | LDH 135–225 U/l | 155 | 170 |
Antithrombin-3 80–120 % | 83 | Amylase 40–140 U/l | 44 | 35 | |
Protein C 70–140 % | 111 | CPK 0–190 U/l | 26 | 146 | |
Free PS 60–140 % | 103 | Cholesterol < 200 mg/dl | 211 | ||
APC Resistance > 2.5 seconds | 179.4 | LDL < 130 mg/dl | 148 | ||
La Ratio < 1.2 | 1.19 | HDL > 65 mg/dl | 28 | ||
RPR | Negative | Total Protein 6.4–8.3 gr/dl | 7.4 | 8 | |
HBsAg | Negative | Albumin 3.5–5.2 gr/dl | 3.3 | 3.8 | |
HIV Ag-Ab | Negative | Fe 33–193 μg/dl | 22 | 54 | |
Procalcitonin | 0.05 | Ferritin 30–400 ng/ml | 71 | 473 | |
CRP < 0.5 mg/dl | 5 | 1.8 | TSH 0.27–4.20 μIU/ml | 0.44 | |
ACE 13.3–63.9 U/L | 4.7 | FT4 12.0–22.0 pmol/l | 0.97 | ||
C3 79–152 mg/dl | 205 | IGG 751–1560 mg/dl | 2153 | ||
C4 16–38 mg/dl | 40 | IGA 82–453 mg/dl | 381 | ||
RA test 0–20 IU/ml | 5 | IGM 46–304 mg/dl | 132 | ||
B12 145–569 pmol/l | 131 | IGE 22–165 IU/ml | 168 | ||
Folic acid 8.83–60.8 nmol/l | 2.90 | C.E.A. < 3.8 ng/ml | 2.63 | ||
Anti-ENA screen < 20 RU/ml | Negative | CA 15.3 < 25 U/ml | 31.7 | ||
Anti-Cardiolipin IGG | < 2 negative | CA 19.9 < 27 U/ml | 20.83 | ||
Anti-Cardiolipin IGM | < 2 negative | CA 125 < 35 U/ml | 57.6 | ||
ANA < 1:160 | Negative | a-FP < 7.0 ng/ml | 1.5 | ||
Anti-ds DNA < 1:10 | Negative | Widal | negative | ||
ANCA-c | < 2 negative | Wright | negative | ||
ANCA-p | < 2 negative | Uric acid 3.4–7.0 mg/dl | 6.3 | 5.9 | |
β2GPI (ΙgG) < 20 RU/ml | < 2 negative | ||||
β2 GPI (IgΜ) < 20 RU/ml | < 2 negative | ||||
Urine examination | |||||
Color | Yellow | Microscopic examination | |||
Appearance | Clear | RBC | 30–50/HPF | ||
Specific Gravity | 1020 | WBC | 8–10/HPF | ||
PH | 7 | ||||
HGB | 25 | ||||
Protein | Trace | ||||
Glucose | Normal | ||||
Urobilinogen | Negative | ||||
Nitrogen | Negative | ||||